Lingue

English italiano
Home page - Attività - Pubblicazioni
 24-Mag-2008   Stampa la pagina corrente   Mostra la posizione di questa pagina nella mappa

Pubblicazioni

  1. Antonelli A, Fallahi P, Rotondi M, Ferrari SM, Romagnani P, Grosso M, Ferrannini E, Serio M. Increased serum CXCL10 in Graves' disease or autoimmune thyroiditis is not associated with hyper- or hypothyroidism per se, but is specifically sustained by the autoimmune, inflammatory process. Eur J Endocrinol. 2006 May;154(5):651-8.

  2. Antonelli A, Fallahi P, Rotondi M, Ferrari SM, Serio M, Miccoli P. Serum levels of the interferon-gamma-inducible alpha chemokine CXCL10 in patients with active Graves' disease, and modulation by methimazole therapy and thyroidectomy. Br J Surg. 2006 Oct;93(10):1226-31.

  3. Antonelli A, Rotondi M, Fallahi P, Ferrari SM, Paolicchi A, Romagnani P, Serio M, Ferrannini E. Increase of CXC chemokine CXCL10 and CC chemokine CCL2 serum levels in normal ageing. Cytokine. 2006 Apr;34(1-2):32-8.

  4. Antonelli A, Rotondi M, Fallahi P, Romagnani P, Ferrari SM, Barani L, Ferrannini E, Serio M. Increase of interferon-gamma-inducible CXC chemokine CXCL10 serum levels in patients with active Graves' disease, and modulation by methimazole therapy. Clin Endocrinol (Oxf). 2006 Feb;64(2):189-95.

  5. Antonelli A, Rotondi M, Fallahi P, Romagnani P, Ferrari SM, Buonamano A, Ferrannini E, Serio M. : High levels of circulating CXC chemokine ligand 10 are associated with chronic autoimmune thyroiditis and hypothyroidism. J Clin Endocrinol Metab. 2004 Nov;89(11):5496-9.

  6. Antonelli A, Rotondi M, Fallahi P, Romagnani P, Ferrari SM, Ferrannini E, Serio M. Age-dependent changes in CXC chemokine ligand 10 serum levels in euthyroid subjects. J Interferon Cytokine Res. 2005 Sep;25(9):547-52.

  7. Antonelli A, Rotondi M, Fallahi P, Romagnani P, Ferrari SM, Paolicchi A, Ferrannini E, Serio M. Increase of interferon-gamma inducible alpha chemokine CXCL10 but not beta chemokine CCL2 serum levels in chronic autoimmune thyroiditis. Eur J Endocrinol. 2005 Feb;152(2):171-7.

  8. Antonelli A, Rotondi M, Ferrari SM, Fallahi P, Romagnani P, Franceschini SS, Serio M, Ferrannini E. Interferon-{gamma}-inducible {alpha}-chemokine CXCL10 involvement in Graves' ophthalmopathy: modulation by peroxisome proliferator-activated receptor-{gamma} agonists. J Clin Endocrinol Metab. 2005 Nov 22.

  9. Baglioni S, Corona G, Maggi M, Serio M, Peri A. Identification of a novel mutation in the arginine vasopressin-neurophysin II gene affecting the sixth intrachain disulfide bridge of the neurophysin II moiety. Eur J Endocrinol. 2004 Nov;151(5):605-11.

  10. Baldi E, Luconi M, Bonaccorsi L, Forti G. Signal transduction pathways in human spermatozoa. J Reprod Immunol. 2002 Jan;53(1-2):121-31. Review.

  11. Benvenuti S, Luciani P, Vannelli GB, Gelmini S, Franceschi E, Serio M, Peri A. : Estrogen and SERMs exert neuroprotective effects and stimulate the expression of seladin-1, a recently discovered anti-apoptotic gene, in human neuroblast long-term cell cultures. J Clin Endocrinol Metab. 2004 Dec 7;

  12. Benvenuti S, Luciani P, Vannelli GB, Gelmini S, Franceschi E, Serio M, Peri A. Estrogen and selective estrogen receptor modulators exert neuroprotective effects and stimulate the expression of selective Alzheimer's disease indicator-1, a recently discovered antiapoptotic gene, in human neuroblast long-term cell cultures. J Clin Endocrinol Metab. 2005 Mar;90(3):1775-82.

  13. Benvenuti S, Saccardi R, Luciani P, Urbani S, Deledda C, Cellai I, Francini F, Squecco R, Rosati F, Danza G, Gelmini S, Greeve I, Rossi M, Maggi R, Serio M, Peri A. Neuronal differentiation of human mesenchymal stem cells: changes in the expression of the Alzheimer's disease-related gene seladin-1. Exp Cell Res. 2006 Aug 1;312(13):2592-604.

  14. Bernini GP, Moretti A, Mannelli M, Ercolino T, Bardini M, Caramella D, Taurino C, Salvetti A. Unique association of non-functioning pheochromocytoma, ganglioneuroma, adrenal cortical adenoma, hepatic and vertebral hemangiomas in a patient with a new intronic variant in the VHL gene. J Endocrinol Invest. 2005 Dec;28(11):1032-7.

  15. Biliotti GC, Martini F, Vezzosi V, Seghi P, Tozzi F, Castagnoli A, Basili G, Peri A. Specific features of differentiated thyroid carcinoma in patients over 70 years of age. J Surg Oncol. 2006 Mar 1;93(3):194-8.

  16. Bonaccorsi L, Marchiani S, Ferruzzi P, Muratori M, Crescioli C, Forti G, Maggi M, Baldi E. Non-genomic effects of the androgen receptor and Vitamin D agonist are involved in suppressing invasive phenotype of prostate cancer cells. Steroids. 2005 Nov 8.

  17. Brewis IA, Moore HD, Fraser LR, Holt WV, Baldi E, Luconi M, Gadella BM, Ford WC, Harrison RA. Molecular mechanisms during sperm capacitation. Hum Fertil (Camb). 2005 Dec;8(4):253-61.

  18. Brouwers FM, Elkahloun AG, Munson PJ, Eisenhofer G, Barb J, Linehan WM, Lenders JW, De Krijger R, Mannelli M, Udelsman R, Ocal IT, Shulkin BL, Bornstein SR, Breza J, Ksinantova L, Pacak K. Gene expression profiling of benign and malignant pheochromocytoma. Ann N Y Acad Sci. 2006 Aug;1073:541-56.

  19. Brouwers FM, Petricoin EF 3rd, Ksinantova L, Breza J, Rajapakse V, Ross S, Johann D, Mannelli M, Shulkin BL, Kvetnansky R, Eisenhofer G, Walther MM, Hitt BA, Conrads TP, Veenstra TD, Mannion DP, Wall MR, Wolfe GM, Fusaro VA, Liotta LA, Pacak K. Low molecular weight proteomic information distinguishes metastatic from benign pheochromocytoma. Endocr Relat Cancer. 2005 Jun;12(2):263-72.

  20. Casini Raggi C, Calabro A, Renzi D, Briganti V, Cianchi F, Messerini L, Valanzano R, Cameron Smith M, Cortesini C, Tonelli F, Serio M, Maggi M, Orlando Quantitative evaluation of somatostatin receptor subtype 2 expression in sporadic colorectal tumor and in the corresponding normal mucosa. Clin Cancer Res 2002 Feb;8(2):419-27

  21. Cellai I, Benvenuti S, Luciani P, Galli A, Ceni E, Simi L, Baglioni S, Muratori M, Ottanelli B, Serio M, Thiele CJ, Peri A. Antineoplastic effects of rosiglitazone and PPARgamma transactivation in neuroblastoma cells. Br J Cancer. 2006 Oct 9;95(7):879-88.

  22. Cellini E, Nacmias B, Brecelj-Anderluh M, Badia-Casanovas A, Bellodi L, Boni C, Di Bella D, Estivill X, Fernandez-Aranda F, Foulon C, Friedel S, Gabrovsek M, Gorwood P, Gratacos M, Guelfi J, Hebebrand J, Hinney A, Holliday J, Hu X, Karwautz A, Kipman A, Komel R, Rotella CM, Ribases M, Ricca V, Romo L, Tomori M, Treasure J, Wagner G, Collier DA, Sorbi S; EC Framework V 'Factors in Healthy Eating' consortium. Case-control and combined family trios analysis of three polymorphisms in the ghrelin gene in European patients with anorexia and bulimia nervosa. Psychiatr Genet. 2006 Apr;16(2):51-2.

  23. Cioppi F, Simi L, Luciani P, Petraglia F, Susini T, Cobellis L, Serio M, Maggi M, Peri A. : Expression of uteroglobin and matrix metalloproteinase-9 genes in endometrial cancer: relationship to estrogen and progesterone receptor status. Oncol Rep. 2004 Feb;11(2):427-33.

  24. Cresci B, Giannini S, Pala L, Mavilia C, Manuelli C, Cappugi P, Magg E, Rotella CM. AT1 and AT2 receptors in human glomerular endothelial cells at different passages. Microvasc Res. 2003 Jul; 66(1): 22-9.

  25. Crescioli C, Ferruzzi P, Caporali A, Mancina R, Comerci A, Muratori M, Scaltriti M, Vannelli GB, Smiroldo S, Mariani R, Villari D, Bettuzzi S, Serio M, Adorini L, Maggi M. Inhibition of spontaneous and androgen-induced prostate growth by a nonhypercalcemic calcitriol analog. Endocrinology. 2003 Jul; 144(7): 3046-57.

  26. Crescioli C, Ferruzzi P, Caporali A, Scaltriti M, Bettuzzi S, Mancina R, Gelmini S, Serio M, Villari D, Vannelli GB, Colli E, Adorini L, Maggi M. : Inhibition of prostate cell growth by BXL-628, a calcitriol analogue selected for a phase II clinical trial in patients with benign prostate hyperplasia. Eur J Endocrinol. 2004 Apr;150(4):591-603.

  27. Crescioli C, Maggi M, Luconi M, Vannelli GB, Salerno R, Sinisi AA, Bonaccorsi L, Ferruzzi P, Barni T, Forti G, Serio M. Vitamin D3 analogue inhibits keratinocyte growth factor signaling and induces apoptosis in human prostate cancer cells. Prostate. 2002 Jan 1;50(1):15-26.

  28. Crescioli C, Maggi M, Vannelli GB, Ferruzzi P, Granchi S, Mancina R, Muratori M, Forti G, Serio M, Luconi M. Expression of functional estrogen receptors in human fetal male external genitalia. J Clin Endocrinol Metab. 2003 Apr; 88(4): 1815-24.

  29. Crescioli C, Morelli A, Adorini L, Ferruzzi P, Luconi M, Vannelli GB, Marini M, Gelmini S, Fibbi B, Donati S, Villari D, Forti G, Colli E, Andersson KE, Maggi M. Human bladder as a novel target for vitamin D receptor ligands. J Clin Endocrinol Metab. 2005 Feb;90(2):962-72.

  30. Crescioli C, Villari D, Forti G, Ferruzzi P, Petrone L, Vannelli GB, Adorini L, Salerno R, Serio M, Maggi M Des (1-3) IGF-I-stimulated growth of human stromal BPH cells is inhibited by a vitamin D (3) analogue. Mol Cell Endocrinol. 2002 Dec 30, 198 (1-2): 69-75.

  31. du Plessis SS, Franken DR, Baldi E, Luconi M. : Phosphatidylinositol 3-kinase inhibition enhances human sperm motility and sperm-zona pellucida binding. Int J Androl. 2004 Feb;27(1):19-26.

  32. Eisenhofer G, Huynh TT, Pacak K, Brouwers FM, Walther MM, Linehan WM, Munson PJ, Mannelli M, Goldstein DS, Elkahloun AG. : Distinct gene expression profiles in norepinephrine- and epinephrine-producing hereditary and sporadic pheochromocytomas: activation of hypoxia-driven angiogenic pathways in von Hippel-Lindau syndrome. Endocr Relat Cancer. 2004 Dec;11(4):897-911.

  33. Eisenhofer G, Lenders JW, Goldstein DS, Mannelli M, Csako G, Walther MM, Brouwers FM, Pacak K. Pheochromocytoma catecholamine phenotypes and prediction of tumor size and location by use of plasma free metanephrines. Clin Chem. 2005 Apr;51(4):735-44.

  34. Ferrali A, Menchi G, Occhiato EG, Danza G, Mancina R, Serio M, Guarna A. Synthesis and activity of 8-substituted benzo[c]quinolizin-3-ones as dual inhibitors of human 5alpha-reductases 1 and 2. Bioorg Med Chem Lett. 2005 Jan 3;15(1):145-8.

  35. Ferrante E, Pellegrini C, Bondioni S, Peverelli E, Locatelli M, Gelmini P, Luciani P, Peri A, Mantovani G, Bosari S, Beck-Peccoz P, Spada A, Lania A. Octreotide promotes apoptosis in human somatotroph tumor cells by activating somatostatin receptor type 2. Endocr Relat Cancer. 2006 Sep;13(3):955-62.

  36. Ferruzzi P, Ceni E, Tarocchi M, Grappone C, Milani S, Galli A, Fiorelli G, Serio M, Mannelli M. Thiazolidinediones inhibit growth and invasiveness of the human adrenocortical cancer cell line H295R. J Clin Endocrinol Metab. 2005 Mar;90(3):1332-9.

  37. Filippi S, Crescioli C, Vannelli GB, Fazzini A, Natali A, Riffaud JP, Maggi M, Ledda F. Effects of NCX 4050, a new NO donor, in rabbit and human corpus cavernosum. Int J Androl. 2003 Apr; 26(2): 101-8.

  38. Filippi S, Luconi M, Granchi S, Natali A, Tozzi P, Forti G, Ledda F, Maggi M. Endothelium-dependency of yohimbine-induced corpus cavernosum relaxation. Int J Impot Res. 2002 Aug;14(4):295-307.

  39. Filippi S, Marini M, Vannelli GB, Crescioli C, Granchi S, Vignozzi L, Luconi M, Ferruzzi P, Morelli A, Forti G, Ledda F, Maggi M. Effects of hypoxia on endothelin-1 sensitivity in the corpus cavernosum. Mol Hum Reprod. 2003 Dec; 9(12): 765-74.

  40. Filippi S, Morelli A, Vignozzi L, Vannelli GB, Marini M, Ferruzzi P, Mancina R, Crescioli C, Mondaini N, Forti G, Ledda F, Maggi M. Oxytocin mediates the estrogen-dependent contractile activity of endothelin-1 in human and rabbit epididymis. Endocrinology. 2005 Aug;146(8):3506-17.

  41. Filippi S, Vannelli G, Granchi S, Luconi M, Crescioli C, Mancina R, Natali A, Brocchi S, Vignozzi L, Bencini E, Noci I, Ledda F, Forti G, Maggi M. Identification, localization and functional activity of oxytocin receptors in epididymis. Mol Cell Endocrinol. 2002 Jul 31;193(1-2):89.

  42. Filippi S., Luconi M., Granchi S., Vignozzi L., Bettuzzi S., Tozzi P., Ledda F., Forti G. & Maggi M. Estrogens, but not androgens, regulate expression and functional activity of oxytocin receptor in rabbit epididymis. Endocrinology, 143: 4271-4280, 2002

  43. Filopanti M, Ballare E, Lania AG, Bondioni S, Verga U, Locatelli M, Zavanone LM, Losa M, Gelmini S, Peri A, Orlando C, Beck-Peccoz P, Spada A. Loss of heterozygosity at the SS receptor type 5 locus in human GH- and TSH-secreting pituitary adenomas. J Endocrinol Invest. 2004 Nov;27(10):937-42.

  44. Filopanti M, Ronchi C, Ballare E, Bondioni S, Lania AG, Losa M, Gelmini S, Peri A, Orlando C, Beck-Peccoz P, Spada A. Analysis of somatostatin receptors 2 and 5 polymorphisms in patients with acromegaly. J Clin Endocrinol Metab. 2005 Aug;90(8):4824-8.

  45. Fontana GA, Pantaleo T, Lavorini F, Bongianni F, Mannelli M, Bridge PD, Pistolesi M. Handgrip-induced airway dilation in asthmatic patients with bronchoconstriction induced by MCh inhalation. J Appl Physiol. 2002 Nov;93(5):1723-30. (2.581)

  46. Gelmini S, Poggesi M, Distante V, Bianchi S, Simi L, Luconi M, Raggi CC, Cataliotti L, Pazzagli M, Orlando C. Tankyrase, a positive regulator of telomere elongation, is over expressed in human breast cancer. Cancer Lett. 2004 Dec 8;216(1):81-7.

  47. Gelmini S, Tricarico C, Petrone L, Forti G, Amorosi A, Dedola GL, Serio M, Pazzagli M, Orlando C. Real-time RT-PCR for the measurement of prostate-specific antigen mRNA expression in benign hyperplasia and adenocarcinoma of prostate. Clin Chem Lab Med. 2003 Mar; 41(3): 261-5.

  48. Genovese S, Bazzigaluppi E, Goncalves D, Ciucci A, Cavallo MG, Purrello F, Anello M, Rotella CM, Bardini G, Vaccaro O, Riccardi G, Travaglini P, Morenghi E, Bosi E, Pozzilli P. Clinical phenotype and beta-cell autoimmunity in Italian patients with adult-onset diabetes. Eur J Endocrinol. 2006 Mar;154(3):441-7.

  49. Giannini S, Cresci B, Manuelli C, Pala L, Rotella CM. Diabetic microangiopathy: IGFBP control endothelial cell growth by a common mechanism in spite of their species specificity and tissue peculiarity. J Endocrinol Invest. 2006 Sep;29(8):754-63. Review.

  50. Gimenez-Roqueplo AP, Lehnert H, Mannelli M, Neumann H, Opocher G, Maher ER, Plouin PF; European Network for the Study of Adrenal Tumours (ENS@T) Pheochromocytoma Working Group. Phaeochromocytoma, new genes and screening strategies. Clin Endocrinol (Oxf). 2006 Dec;65(6):699-705.

  51. Gorwood P., Adès J., Bellodi L., Cellini E., Collier D.A., Di Bella D., Di Bernardo M., Estivill X., Fernandez-Aranda F., Gratacos M., Hebebrand J., Hinney A., Hu X., Karwautz A., Kipman A., Mouren-Siméoni M.C., Nacmias B., Ribasés M., Remschmidt H., Ricca V., Rotella C.M., Sorbi S., Treasure J. (2002) The 5-HT2A –1438G/A polymorphism in anorexia nervosa: A combined analysis of 316 trios from six European centers. Molecular Psychiatry 7: 90-94 (I.F.: 6.250)

  52. Granchi S., Vannelli GB., Vignozzi L., Crescioli C., Ferruzzi P., Mancina R., Vinci MC., Forti G., Filippi S., Luconi M., Ledda F., Maggi M. Expression and regulation of endothelin-1 and its receptors in human penile smooth muscle cells. Mol Hum Reprod, 2002, 8 (12):1053-64

  53. Imperiale A, Olianti C, Mannelli M, La Cava G, Pupi A. Tomographic evaluation of [131I] 6beta-iodomethyl-norcholesterol standardised uptake trend in clinically silent monolateral and bilateral adrenocortical incidentalomas. Q J Nucl Med Mol Imaging. 2005 Sep;49(3):287-96.

  54. La Cava G, Imperiale A, Olianti C, Gheri GR, Ladu C, Mannelli M, Pupi A. SPECT semiquantitative analysis of adrenocortical (131)I-6 beta iodomethyl-norcholesterol uptake to discriminate subclinical and preclinical functioning adrenal incidentaloma. J Nucl Med. 2003 Jul; 44(7): 1057-64.

  55. Lasagni L, Francalanci M, Annunziato F, Lazzeri E, Giannini S, Cosmi L, Sagrinati C, Mazzinghi B, Orlando C, Maggi E, Marra F, Romagnani S, Serio M, Romagnani P. An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4. J Exp Med. 2003 Jun 2; 197(11): 1537-49.

  56. Lazzeri E, Rotondi M, Mazzinghi B, Lasagni L, Buonamano A, Rosati A, Pradella F, Fossombroni V, La Villa G, Gacci M, Bertoni E, Serio M, Salvadori M, Romagnani P. High CXCL10 expression in rejected kidneys and predictive role of pretransplant serum CXCL10 for acute rejection and chronic allograft nephropathy. Transplantation. 2005 May 15;79(9):1215-20.

  57. Lenders JW, Eisenhofer G, Mannelli M, Pacak K. Phaeochromocytoma. Lancet. 2005 Aug 20-26;366(9486): 665-75. Review.

  58. Lenders JW, Pacak K, Walther MM, Linehan WM, Mannelli M, Friberg P, Kaiser HR, Goldstein DS, Eisenhofer G. Biochemical diagnosis of pheochromocytoma: which test is best? JAMA 287: 1427-1434, 2002

  59. Luciani P, Buci L, Conforti B, Tonacchera M, Agretti P, Elisei R, Vivaldi A, Cioppi F, Biliotti G, Manca G, Vitti P, Serio M, Peri A. Expression of cAMP response element-binding protein and sodium iodide symporter in benign non-functioning and malignant thyroid tumours. Eur J Endocrinol. 2003 May; 148(5): 579-86.

  60. Luciani P, Ferruzzi P, Arnaldi G, Crescioli C, Benvenuti S, Nesi G, Valeri A, Greeve I, Serio M, Mannelli M, Peri A. : Expression of the novel adrenocorticotropin-responsive gene selective Alzheimer's disease indicator-1 in the normal adrenal cortex and in adrenocortical adenomas and carcinomas. J Clin Endocrinol Metab. 2004 Mar;89(3):1332-9.

  61. Luciani P, Gelmini S, Ferrante E, Lania A, Benvenuti S, Baglioni S, Mantovani G, Cellai I, Ammannati F, Spada A, Serio M, Peri A. Expression of the antiapoptotic gene seladin-1 and octreotide-induced apoptosis in growth hormone-secreting and nonfunctioning pituitary adenomas. J Clin Endocrinol Metab. 2005 Nov;90(11):6156-61.

  62. Luconi M, Baldi E. How do sperm swim? Molecular mechanisms underlying sperm motility.Cell Mol Biol (Noisy-le-grand). 2003 May; 49(3): 357-69.

  63. Luconi M, Bonaccorsi L, Bini L, Liberatori S, Pallini V, Forti G, Baldi E. Characterization of membrane nongenomic receptors for progesterone in human spermatozoa. Steroids. 2002 May;67(6):505-9.

  64. Luconi M, Carloni V, Marra F, Ferruzzi P, Forti G, Baldi E. : Increased phosphorylation of AKAP by inhibition of phosphatidylinositol 3-kinase enhances human sperm motility through tail recruitment of protein kinase A. J Cell Sci. 2004 Mar 1;117(Pt 7):1235-46.

  65. Luconi M, Forti G, Baldi E. Genomic and nongenomic effects of estrogens: molecular mechanisms of action and clinical implications for male reproduction. J Steroid Biochem Mol Biol. 2002 Apr;80(4-5):369-81.Review.

  66. Luconi M, Francavilla F, Porazzi I, Macerola B, Forti G, Baldi E. : Human spermatozoa as a model for studying membrane receptors mediating rapid nongenomic effects of progesterone and estrogens. Steroids. 2004 Aug;69(8-9):553-9.

  67. Luconi M, Porazzi I, Ferruzzi P, Marchiani S, Forti G, Baldi E. Tyrosine phosphorylation of the a kinase anchoring protein 3 (AKAP3) and soluble adenylate cyclase are involved in the increase of human sperm motility by bicarbonate. Biol Reprod. 2005 Jan;72(1):22-32.

  68. Luconi M, Torcia S, Grillo D, Fiorenza MT, Forti G, Mangia F, Baldi E. Enhancement of mouse sperm motility by the PI3-kinase inhibitor LY294002 does not result in toxic effects on preimplantation embryo development. Hum Reprod. 2005 Dec;20(12):3500-4.

  69. Malentacchi F, Marzocchini R, Gelmini S, Orlando C, Serio M, Ramponi G, Raugei G. Up-regulated expression of low molecular weight protein tyrosine phosphatases in different human cancers. Biochem Biophys Res Commun. 2005 Sep 2;334(3):875-83.

  70. Mannelli M, Ferruzzi P, Luciani P, Crescioli C, Buci L, Corona G, Serio M, Peri A. Cushing's syndrome in a patient with bilateral macronodular adrenal hyperplasia responding to cisapride: an in vivo and in vitro study. J Clin Endocrinol Metab. 2003 Oct; 88(10): 4616-22.

  71. Mannelli M, Simi L, Ercolino T, Gagliano MS, Becherini L, Vinci S, Sestini R, Gensini F, Pinzani P, Mascalchi M, Guerrini L, Pratesi C, Nesi G, Torti F, Cipollini F, Bernini GP, Genuardi M. SDH mutations in patients affected by paraganglioma syndromes: a personal experience. Ann N Y Acad Sci. 2006 Aug;1073:183-9.

  72. Mannelli M. Management and treatment of pheochromocytomas and paragangliomas. Ann N Y Acad Sci. 2006 Aug;1073:405-16.

  73. Mannelli M. Pheochromocytoma: a permanent challenge for the clinical endocrinologist. J Endocrinol Invest. 2003 May; 26(5): 387-8.

  74. Mannucci E, Bardini G, Rotella CM. Effect of lower diagnostic thresholds on estimates of prevalence of impaired fasting glucose (IFG). Diabet Med. 2005 Mar;22(3):353-4.

  75. Mannucci E, Bardini G, Rotella F, Rotella CM. Comparison among different insulin sensitivity indices in obese patients.Diabet Med. 2003 Jun; 20(6): 462-6.

  76. Mannucci E, Monami M, Pala L, Cocca C, Cresci B, Bardini G, Masotti G, Marchionni N, Rotella CM. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2007 Jan;30(1):193-4.

  77. Mannucci E, Ognibene A, Cremasco F, Dicembrini I, Bardini G, Brogi M, Terreni A, Caldini A, Messeri G, Rotella CM. Plasma adiponectin and hyperglycaemia in diabetic patients. Clin Chem Lab Med. 2003 Sep; 41(9): 1131-5.

  78. Mannucci E, Ognibene A, Sposato I, Brogi M, Gallori G, Bardini G, Cremasco F, Messeri G, Rotella CM. Fasting plasma glucose and glycated haemoglobin in the screening of diabetes and impaired glucose tolerance. Acta Diabetol. 2003 Dec; 40(4): 181-6.

  79. Mannucci E, Pala L, Ciani S, Bardini G, Pezzatini A, Sposato I, Cremasco F, Ognibene A, Rotella CM. Hyperglycaemia increases dipeptidyl peptidase IV activity in diabetes mellitus. Diabetologia. 2005 Jun;48(6):1168-72.

  80. Mannucci E, Pala L, Rotella CM. Long-term interactive group education for type 1 diabetic patients. Acta Diabetol. 2005 Mar;42(1):1-6.

  81. Mannucci E, Rotella F, Ricca V, Moretti S, Placidi GF, Rotella CM. Eating disorders in patients with type 1 diabetes: a meta-analysis. J Endocrinol Invest. 2005 May;28(5):417-9.

  82. Mannucci E, Tesi F, Ricca V, Pierazzuoli E, Barciulli E, Moretti S, Di Bernardo M, Travaglini R, Carrara S, Zucchi T, Placidi GF, Rotella CM. Eating behavior in obese patients with and without type 2 diabetes mellitus. Int J Obes Relat Metab Disord. 2002 Jun;26(6):848-53.

  83. Marchiani S, Bonaccorsi L, Ferruzzi P, Crescioli C, Muratori M, Adorini L, Forti G, Maggi M, Baldi E. The vitamin D analogue BXL-628 inhibits growth factor-stimulated proliferation and invasion of DU145 prostate cancer cells. J Cancer Res Clin Oncol. 2006 Jun;132(6):408-16.

  84. Massi D, Tarantini F, Franchi A, Paglierani M, Di Serio C, Pellerito S, Leoncini G, Cirino G, Geppetti P, Santucci M. Evidence for differential expression of the Notch receptors and their ligands in melanocytic nevi and cutaneous malignant melanoma. Mod Pathol 2006;19:246-54.

  85. Morelli A, Filippi S, Mancina R, Luconi M, Vignozzi L, Marini M, Orlando C, Vannelli GB, Aversa A, Natali A, Forti G, Giorgi M, Jannini EA, Ledda F, Maggi M. : Androgens regulate phosphodiesterase type 5 expression and functional activity in corpora cavernosa. Endocrinology. 2004 May;145(5):2253-63.

  86. Morelli A, Filippi S, Zhang XH, Luconi M, Vignozzi L, Mancina R, Maggi M. Peripheral regulatory mechanisms in erection. Int J Androl. 2005 Dec;28 Suppl 2:23-7. Review.

  87. Morelli A, Vignozzi L, Filippi S, Vannelli GB, Ambrosini S, Mancina R, Crescioli C, Donati S, Fibbi B, Colli E, Adorini L, Maggi M. BXL-628, a vitamin D receptor agonist effective in benign prostatic hyperplasia treatment, prevents RhoA activation and inhibits RhoA/Rho kinase signaling in rat and human bladder. Prostate. 2007 Feb 15;67(3):234-47.

  88. Moretti A, Minuto M, Berti P, Bernini GP, Mannelli M, Miccoli P. Unusual association of adrenal pheochromocytoma and para-aortic neurofibroma in pregnancy. J Endocrinol Invest. 2006 Sep;29(8):738-41.

  89. Muratori M, Porazzi I, Luconi M, Marchiani S, Forti G, Baldi E. : AnnexinV binding and merocyanine staining fail to detect human sperm capacitation. J Androl. 2004 Sep-Oct;25(5):797-810.

  90. Occhiato EG, Ferrali A, Menchi G, Guarna A, Danza G, Comerci A, Mancina R, Serio M, Garotta G, Cavalli A, De Vivo M, Recanatini M. Synthesis, biological activity, and three-dimensional quantitative structure-activity relationship model for a series of benzo[c]quinolizin-3-ones, nonsteroidal inhibitors of human steroid 5alpha-reductase 1. J Med Chem. 2004 Jul 1;47(14):3546-60.

  91. Occhiato EG, Guarna A, Danza G, Serio M. : Selective non-steroidal inhibitors of 5 alpha-reductase type 1. J Steroid Biochem Mol Biol. 2004 Jan;88(1):1-16. Review.

  92. Ognibene A, Mannucci E, Caldini A, Terreni A, Brogi M, Bardini G, Sposato I, Mosconi V, Salvadori B, Rotella CM, Messeri G. Cystatin C reference values and aging. Clin Biochem. 2006 Jun;39(6):658-61.

  93. Orlando C, Raggi CC, Bianchi S, Distante V, Simi L, Vezzosi V, Gelmini S, Pinzani P, Smith MC, Buonamano A, Lazzeri E, Pazzagli M, Cataliotti L, Maggi M, Serio M. : Measurement of somatostatin receptor subtype 2 mRNA in breast cancer and corresponding normal tissue. Endocr Relat Cancer. 2004 Jun;11(2):323-32.

  94. Pala L, Cresci B, Manuelli C, Maggi E, Yamaguchi YF, Cappugi P, Rotella CM, Giannini S. Vascular endothelial growth factor receptor-2 and low affinity VEGF binding sites on human glomerular endothelial cells: Biological effects and advanced glycosilation end products modulation. Microvasc Res. 2005 Nov;70(3):179-88.

  95. Pala L, Mannucci E, Pezzatini A, Ciani S, Sardi J, Raimondi L, Ognibene A, Cappadona A, Vannelli BG, Rotella CM. Dipeptidyl peptidase-IV expression and activity in human glomerular endothelial cells. Biochem Biophys Res Commun. 2003 Oct 10; 310(1): 28-31.

  96. Parenti G, Nassi R, Silvestri S, Bianchi S, Valeri A, Manca G, Mangiafico S, Ammannati F, Serio M, Mannelli M, Peri A. Multi-step approach in a complex case of Cushing's syndrome and medullary thyroid carcinoma. J Endocrinol Invest. 2006 Feb;29(2):177-81.

  97. Pasquali R, Ambrosi B, Armanini D, Cavagnini F, Uberti ED, Del Rio G, de Pergola G, Maccario M, Mantero F, Marugo M, Rotella CM, Vettor R; Study Group on Obesity of the Italian Society of Endocrinology. Cortisol and ACTH response to oral dexamethasone in obesity and effects of sex, body fat distribution, and dexamethasone concentrations: a dose-response study. J Clin Endocrinol Metab. 2002 Jan;87(1):166-75.

  98. Peri A, Danza G, Serio M. Seladin-1 as a target of estrogen receptor activation in the brain: a new gene for a rather old story? J Endocrinol Invest. 2005 Mar;28(3):285-93. Review.

  99. Peri, A., Luciani, P., Tonacchera, M., Agretti, P., Baglioni-Peri, S., Buci, L., Conforti, B., Cioppi, F., Biliotti, G., Serio, M., Vitti, P., Chiovato, L. Expression of cAMP-responsive element binding protein and inducile cAMP early repressor in hyperfunctioning thyroid adenomas. Eur. J. Endocrinol., 146:759-766, 2002

  100. Pitozzi V, Giovannelli L, Bardini G, Rotella CM, Dolara P. Oxidative DNA damage in peripheral blood cells in type 2 diabetes mellitus: higher vulnerability of polymorphonuclear leukocytes. Mutat Res. 2003 Aug 28; 529(1-2): 129-33.

  101. Raggi CC, Cianchi F, Valanzano R, Smith MC, Serio M, Maggi M, Orlando C. Prognostic value of somatostatin receptor subtype 2 expression in colorectal cancer. Regul Pept. 2005 Dec 15;132(1-3):23-6.

  102. Ravaldi C, Barboni E, Lai M, Rotella CM, Vannacci A, Ricca V. Obesity and mood disorders: the complex problem of insight. J Clin Psychiatry. 2005 Feb;66(2):265.

  103. Ravaldi C, Vannacci A, Truglia E, Zucchi T, Mannucci E, Rotella CM, Faravelli C, Ricca V. The Eating Disorder Examination as a retrospective interview.Eat Weight Disord. 2004 Sep;9(3):228-31.

  104. Ravaldi C, Vannacci A, Zucchi T, Mannucci E, Cabras PL, Boldrini M, Murciano L, Rotella CM, Ricca V. Eating disorders and body image disturbances among ballet dancers, gymnasium users and body builders. Psychopathology. 2003 Sep-Oct; 36(5): 247-54.

  105. Ricca V, Nacmias B, Boldrini M, Cellini E, di Bernardo M, Ravaldi C, Tedde A, Bagnoli S, Placidi GF, Rotella CM, Sorbi S. : Psychopathological traits and 5-HT2A receptor promoter polymorphism (-1438 G/A) in patients suffering from Anorexia Nervosa and Bulimia Nervosa. Neurosci Lett. 2004 Jul 22;365(2):92-6.

  106. Ricca V, Nacmias B, Cellini E, Di Bernardo M, Rotella CM e Sorbi S (2002) 5-HT2A receptor gene polymorhism and eating disorders. Neuroscience Letters 323: 105-108.

  107. Romanelli RG, Barni T, Maggi M, Luconi M, Failli P, Pezzatini A, Pelo E, Torricelli F, Crescioli C, Ferruzzi P, Salerno R, Marini M, Rotella CM, Vannelli GB. Expression and function of gonadotropin-releasing hormone (GnRH) receptor in human olfactory GnRH-secreting neurons: an autocrine GnRH loop underlies neuronal migration. J Biol Chem. 2004 Jan 2;279(1):117-26.

  108. Romanelli RG, Barni T, Maggi M, Luconi M, Failli P, Pezzatini A, Morelli A, Maggi R, Zaninetti R, Salerno R, Ambrosini S, Marini M, Rotella CM, Vannelli GB. Role of endothelin-1 in the migration of human olfactory gonadotropin-releasing hormone-secreting neuroblasts. Endocrinology. 2005 Oct;146(10):4321-30.

  109. Rosati F, Bardazzi I, De Blasi P, Simi L, Scarpi D, Guarna A, Serio M, Racchi ML, Danza G. 5alpha-Reductase activity in Lycopersicon esculentum: cloning and functional characterization of LeDET2 and evidence of the presence of two isoenzymes. J Steroid Biochem Mol Biol. 2005 Aug;96(3-4):287-99.

  110. Rosati F, Danza G, Guarna A, Cini N, Racchi ML, Serio M. New evidence of similarity between human and plant steroid metabolism: 5alpha-reductase activity in Solanum malacoxylon. Endocrinology. 2003 Jan; 144(1): 220-9.

  111. Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C, Ganzaroli C, Giacchetti G, Letizia C, Maccario M, Mallamaci F, Mannelli M, Mattarello MJ, Moretti A, Palumbo G, Parenti G, Porteri E, Semplicini A, Rizzoni D, Rossi E, Boscaro M, Pessina AC, Mantero F; PAPY Study Investigators. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol. 2006 Dec 5;48(11):2293-300.

  112. Rossi GP, Bernini G, Desideri G, Fabris B, Ferri C, Giacchetti G, Letizia C, Maccario M, Mannelli M, Matterello MJ, Montemurro D, Palumbo G, Rizzoni D, Rossi E, Pessina AC, Mantero F; PAPY Study Participants. Renal damage in primary aldosteronism: results of the PAPY Study. Hypertension. 2006 Aug;48(2):232-8.

  113. Rotella CM, Pala L, Mannucci E. Glucagon-like peptide 1 (GLP-1) and metabolic diseases. J Endocrinol Invest. 2005 Sep;28(8):746-58.

  114. Rotondi M, Falorni A, De Bellis A, Laureti S, Ferruzzi P, Romagnani P, Buonamano A, Lazzeri E, Crescioli C, Mannelli M, Santeusanio F, Bellastella A, Serio M. Elevated serum interferon-gamma-inducible chemokine-10/CXC chemokine ligand-10 in autoimmune primary adrenal insufficiency and in vitro expression in human adrenal cells primary cultures after stimulation with proinflammatory cytokines. J Clin Endocrinol Metab. 2005 Apr;90(4):2357-63.

  115. Rotondi M, Romagnani P, Brozzetti A, Santeusanio F, Serio M, Falorni A. -to: Nicoletti F, Conget L, Di Mauro M et al. (2002) Serum concentrations of the interferon-alpha-inducible chemokine IP-10/CXCL10 are augmented in both newly-diagnosed Type I diabetes mellitus patients and subjects at risk of developing the disease. Diabetologia 45:1107-1110. Diabetologia. 2003 Jul; 46(7): 1020-1.

  116. Rotondi M, Rosati A, Buonamano A, Lasagni L, Lazzeri E, Pradella F, Fossombroni V, Cirami C, Liotta F, La Villa G, Serio M, Bertoni E, Salvadori M, Romagnani P. : High pretransplant serum levels of CXCL10/IP-10 are related to increased risk of renal allograft failure. Am J Transplant. 2004 Sep;4(9):1466-74.

  117. Sagrinati C, Netti GS, Mazzinghi B, Lazzeri E, Liotta F, Frosali F, Ronconi E, Meini C, Gacci M, Squecco R, Carini M, Gesualdo L, Francini F, Maggi E, Annunziato F, Lasagni L, Serio M, Romagnani S, Romagnani P. Isolation and characterization of multipotent progenitor cells from the Bowman's capsule of adult human kidneys. J Am Soc Nephrol. 2006 Sep;17(9):2443-56.

  118. Scarpi D, Occhiato E, Danza G, Serio M, Guarna A. Synthesis of 17beta-N-Substituted 19-Nor-10-azasteroids as Inhibitors of Human 5alpha-Reductases I and II. Bioorg Med Chem. 2002 Nov;10(11):3455

  119. Simi L, Andreani M, Davini F, Janni A, Pazzagli M, Serio M, Orlando C. : Simultaneous measurement of MMP9 and TIMP1 mRNA in human non small cell lung cancers by multiplex real time RT-PCR. Lung Cancer. 2004 Aug;45(2):171-9.

  120. Simi L, Sestini R, Ferruzzi P, Gagliano MS, Gensini F, Mascalchi M, Guerrini L, Pratesi C, Pinzani P, Nesi G, Ercolino T, Genuardi M, Mannelli M. Phenotype variability of neural crest derived tumours in six Italian families segregating the same founder SDHD mutation Q109X. J Med Genet. 2005 Aug;42(8):e52.

  121. Sofi F, Innocenti G, Dini C, Masi L, Battistini NC, Brandi ML, Rotella CM, Gensini GF, Abbate R, Surrenti C, Casini A. Low adherence of a clinically healthy Italian population to nutritional recommendations for primary prevention of chronic diseases. Nutr Metab Cardiovasc Dis. 2006 Sep;16(6):436-44.

  122. Terzolo M, Bovio S, Pia A, Conton PA, Reimondo G, Dall'Asta C, Bemporad D, Angeli A, Opocher G, Mannelli M, Ambrosi B, Mantero F. Midnight serum cortisol as a marker of increased cardiovascular risk in patients with a clinically inapparent adrenal adenoma. Eur J Endocrinol. 2005 Aug;153(2):307-15.

  123. Truglia E, Mannucci E, Lassi S, Rotella CM, Faravelli C, Ricca V. Aggressiveness, anger and eating disorders: a review. Psychopathology. 2006;39(2):55-68. Review.

  124. Valeri A, Bergamini C, Manca G, Mannelli M, Presenti L, Peri A, Borrelli A, Tonelli P. Adrenal incidentaloma: the influence of a decision-making algorithm on the short-term outcome of laparoscopy. J Laparoendosc Adv Surg Tech A. 2005 Oct;15(5):451-9.

  125. Vannacci A, Ravaldi C, Giannini L, Rotella CM, Masini E, Faravelli C, Ricca V. Increased nitric oxide production in eating disorders. Neurosci Lett. 2006 May 22;399(3):230-3.

  126. Vignozzi L, Filippi S, Luconi M, Morelli A, Mancina R, Marini M, Vannelli GB, Granchi S, Orlando C, Gelmini S, Ledda F, Forti G, Maggi M. : Oxytocin receptor is expressed in the penis and mediates an estrogen-dependent smooth muscle contractility. Endocrinology. 2004 Apr;145(4):1823-34.

  127. Vignozzi L, Filippi S, Morelli A, Ambrosini S, Luconi M, Vannelli GB, Donati S, Crescioli C, Zhang XH, Mirone V, Forti G, Maggi M. Effect of chronic tadalafil administration on penile hypoxia induced by cavernous neurotomy in the rat. J Sex Med. 2006 May;3(3):419-31.

  128. Vignozzi L, Vannelli GB, Morelli A, Mancina R, Marini M, Ferruzzi P, Crescioli C, Luconi M, Donati S, Fisher AD, Baldi E, Filippi S, Forti G, Maggi M. Identification, characterization and biological activity of oxytocin receptor in the developing human penis. Mol Hum Reprod. 2005 Feb;11(2):99-106.

  129. Zhang XH, Filippi S, Morelli A, Vignozzi L, Luconi M, Donati S, Forti G, Maggi M. Testosterone restores diabetes-induced erectile dysfunction and sildenafil responsiveness in two distinct animal models of chemical diabetes. J Sex Med. 2006 Mar;3(2):253-64; discussion 264-5, author reply 265-6. Erratum in: J Sex Med. 2006 May;3(3):573.

  130. Zhang XH, Filippi S, Vignozzi L, Morelli A, Mancina R, Luconi M, Donati S, Marini M, Vannelli GB, Forti G, Maggi M. Identification, localization and functional in vitro and in vivo activity of oxytocin receptor in the rat penis. J Endocrinol. 2005 Mar;184(3):567-76.

  131. Zhang XH, Morelli A, Luconi M, Vignozzi L, Filippi S, Marini M, Vannelli GB, Mancina R, Forti G, Maggi M. Testosterone regulates PDE5 expression and in vivo responsiveness to tadalafil in rat corpus cavernosum. Eur Urol. 2005 Mar;47(3):409-16.

  132. Zogheri A, Di Mambro A, Mannelli M, Serio M, Forti G, Peri A. Hyponatremia and pituitary adenoma: think twice about the etiopathogenesis.J Endocrinol Invest. 2006 Sep;29(8):750-3.
 
Home page - Attività - Pubblicazioni

Viale Pieraccini, 6
50139 Firenze (FI)

telefoni - fax
email - PEC

|sedi - mappe

Marsilius - Motore di ricerca dell'Ateneo Fiorentino - logo
 
- progetto e idea grafica CSIAF - contenuti e gestione a cura del Dipartimento - Responsabile Tecnico del sito